However, the subgroup analysis of STEMI patients in PLATO showed only a numerical trend toward benefit without reaching statistical significance for the primary endpoint.
← all excerpts
Ticagrelor versus clopidogrel in STEMI post-PCI: A mixed-design meta-analysis of efficacy and safety.
1
—
—